Using Genomics to Improve Lung Cancer Treatment

October 23, 2014 2:20 pm
0 Comments comment
New Advances in Lung Cancer Research

Genomics – the study of the genetic makeup of an organism – helps researchers and oncologists pinpoint why there is no routine lung cancer. Every lung cancer has a unique set of genetic abnormalities, and studying an individual’s genomics allows experts to gain insights into that person’s unique cancer. “It could be the genomics that you inherit from your parents that predisposes you to developing cancer,” says David Carbone,...
Read More

Total Cancer Care: A Patient Partnership to Further Cancer Research

October 9, 2014 4:39 pm
0 Comments comment
Total Cancer Care- A Patient Partnership to Further Cancer Research

At The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James), physicians and researchers understand that there is no routine cancer. Because cancers are so unique, experts need many tissue samples to study a particular type of cancer. “Cancer is very different from, say, heart disease, which may have only four or five causes,” says Michael A. Caligiuri, MD, director of...
Read More

New Advances in Lung Cancer Research

September 25, 2014 4:00 pm
0 Comments comment
New Advances in Lung Cancer Research

Every day, experts at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James) are making advances in cancer research and treatment. These advances are especially important in cancers for which treatment is a challenge for oncologists, like lung cancer. “Lung cancer is often diagnosed in a very late stage,” says David Carbone, MD, PhD, a medical oncologist at the OSUCCC...
Read More

OCCPI: Pelotonia-Funded Research Saves Lives of At-Risk Family Members

September 16, 2014 3:07 pm
1 Comment comment
OCCPI- Pelotonia-Funded Research Saves Lives of At-Risk Family Members

James McDaniel’s colon cancer diagnosis came as no surprise. His father, uncle and grandfather all succumbed to the disease in their mid-40s. “I’d been expecting it,” says McDaniel, who was age 48 at the time of his diagnosis. A vice president of the mortgage division at Huntington and father of three daughters, McDaniel had been cleared during his cancer screening at age 44 and told to come back for...
Read More